A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain cancer known for its quick growth and unresponsiveness to standard treatments. Investigations are constantly underway to identify new management strategies, and recently, a new biomarker named LCA168 has emerged as a potential avenue for GBM treatment. LCA168 is a protein that is abundantly produced in glioblasto